Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.75%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$38.8B
AUM Growth
-$1.01B
(-2.5%)
Cap. Flow
-$4.03B
Cap. Flow
% of AUM
-10.37%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
3,658
New
595
Increased
588
Reduced
695
Closed
822
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$311M |
| 2 |
Biogen
BIIB
|
+$303M |
| 3 |
Nike
NKE
|
+$268M |
| 4 |
Alibaba
BABA
|
+$261M |
| 5 |
Citigroup
C
|
+$252M |
Top Sells
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$319M |
| 3 |
JPMorgan Chase
JPM
|
+$301M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$232M |
| 5 |
Boston Scientific
BSX
|
+$197M |
Sector Composition
| 1 | Financials | 17.87% |
| 2 | Healthcare | 17.83% |
| 3 | Technology | 16.43% |
| 4 | Consumer Discretionary | 15.13% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Bausch + Lomb
BLCO
$5.38B
| $903K | ﹤0.01% |
+58,245
| New | +$903K |
|
1602
Bath & Body Works
BBWI
$5.67B
| $902K | ﹤0.01% |
+21,400
| New | +$902K |
|
|
IGTA
1603
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
| $896K | ﹤0.01% |
88,097
| – | – |
|
1604
Concrete Pumping Holdings
BBCP
$367M
| $893K | ﹤0.01% |
+152,647
| New | +$893K |
|
1605
FormFactor
FORM
$2.34B
| $885K | ﹤0.01% |
39,822
-100,387
| -72% | -$2.23M |
|
1606
Asbury Automotive
ABG
$4.91B
| $881K | ﹤0.01% |
4,917
-31,562
| -87% | -$5.66M |
|
1607
Fidelity MSCI Health Care Index ETF
FHLC
$2.49B
| $877K | ﹤0.01% |
+13,700
| New | +$877K |
|
1608
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$55B
| $874K | ﹤0.01% |
+11,279
| New | +$874K |
|
|
PGTI
1609
DELISTED
PGT, Inc.
PGTI
| $871K | ﹤0.01% |
+48,491
| New | +$871K |
|
1610
California Resources
CRC
$4.43B
| $870K | ﹤0.01% |
+20,000
| New | +$870K |
|
1611
Solidion Technology
STI
$15.4M
| $868K | ﹤0.01% |
1,616
-5
| -0.3% | -$2.69K |
|
1612
ACM Research
ACMR
$1.93B
| $867K | ﹤0.01% |
+112,456
| New | +$867K |
|
1613
Runway Growth Finance
RWAY
$381M
| $864K | ﹤0.01% |
74,576
+57,196
| +329% | +$663K |
|
1614
Ameresco
AMRC
$1.44B
| $862K | ﹤0.01% |
+15,082
| New | +$862K |
|
1615
Olin
OLN
$3.05B
| $860K | ﹤0.01% |
16,246
+6,500
| +67% | +$344K |
|
1616
Mitek Systems
MITK
$470M
| $860K | ﹤0.01% |
+88,746
| New | +$860K |
|
1617
ProPhase Labs
PRPH
$20.9M
| $858K | ﹤0.01% |
89,128
+3,035
| +4% | +$29.2K |
|
1618
CBIZ
CBZ
$3.1B
| $853K | ﹤0.01% |
18,212
-11,944
| -40% | -$560K |
|
|
GRTS
1619
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $850K | ﹤0.01% |
246,326
+212,710
| +633% | +$734K |
|
1620
Bassett Furniture
BSET
$149M
| $844K | ﹤0.01% |
48,574
-87
| -0.2% | -$1.51K |
|
|
HT
1621
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $844K | ﹤0.01% |
+99,047
| New | +$844K |
|
1622
The Greenbrier Companies
GBX
$1.43B
| $843K | ﹤0.01% |
25,127
+3,877
| +18% | +$130K |
|
|
SIVB
1623
DELISTED
SVB Financial Group
SIVB
| $840K | ﹤0.01% |
+3,649
| New | +$840K |
|
1624
Aurinia Pharmaceuticals
AUPH
$1.67B
| $839K | ﹤0.01% |
+194,281
| New | +$839K |
|
1625
NVR
NVR
$23.4B
| $835K | ﹤0.01% |
181
-47
| -21% | -$217K |
|